financetom
Business
financetom
/
Business
/
Materion Q3 Adjusted Earnings Flat, Sales Rise; Reiterates 2025 EPS Guidance
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Materion Q3 Adjusted Earnings Flat, Sales Rise; Reiterates 2025 EPS Guidance
Oct 29, 2025 4:40 AM

07:21 AM EDT, 10/29/2025 (MT Newswires) -- Materion ( MTRN ) reported Q3 adjusted earnings Wednesday of $1.41 per diluted share, unchanged from a year earlier.

Analysts polled by FactSet expected $1.41.

Net sales for the quarter ended Sept. 26 were $444.8 million, compared with $436.7 million a year earlier.

Analysts surveyed by FactSet expected $442.6 million.

The company reiterated its 2025 adjusted EPS guidance of between $5.30 and $5.70. Analysts polled by FactSet expect $5.51.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Some 40% of regions, cities and companies lack emissions-cut targets, survey says
Some 40% of regions, cities and companies lack emissions-cut targets, survey says
Sep 22, 2024
SINGAPORE, Sept 23 (Reuters) - More than 40% of major companies, cities and regions have still not set any targets to cut greenhouse gas emissions, according to an annual stocktake released on Monday to gauge global progress in the fight against catastrophic climate change. While more governments and enterprises have issued net-zero pledges since last year, their attention has been...
Scisparc Submits FDA Investigational New Drug Application for Tourette Syndrome Treatment
Scisparc Submits FDA Investigational New Drug Application for Tourette Syndrome Treatment
Sep 22, 2024
05:10 AM EDT, 09/19/2024 (MT Newswires) -- Scisparc ( SPRC ) said late Wednesday it has submitted an investigational new drug application to the US Food and Drug Administration for a phase 2b trial of SCI-110 as potential treatment of Tourette Syndrome. The company said it has already secured approvals to test the drug's efficacy, safety and tolerability at sites...
AlShaya Starbucks franchise stake sale talks on hold, sources say
AlShaya Starbucks franchise stake sale talks on hold, sources say
Sep 22, 2024
DUBAI/LONDON, Sept 19 (Reuters) - The sale of a stake in the Middle East, North Africa and central Asia Starbucks franchise operated by Kuwait's AlShaya Group is on hold, two people with knowledge of the process said. Boycotts and geopolitical unrest in the region continue to impact the franchise, hindering bidders' ability to value the business, and AlShaya is not...
EU car sales at 3-year low in August, EV sales plunge 44%
EU car sales at 3-year low in August, EV sales plunge 44%
Sep 22, 2024
(Reuters) -New car sales in the European Union fell 18.3% in August to their lowest in three years, dragged down by double-digit losses in major markets Germany, France and Italy and sliding electric vehicle (EV) sales, auto industry body data showed on Thursday. The data showed the fourth consecutive monthly drop in EV sales, prompting the European Automobile Manufacturers' Association...
Copyright 2023-2026 - www.financetom.com All Rights Reserved